171 related articles for article (PubMed ID: 31897456)
1. Fabrication of a water-soluble near-infrared fluorescent probe for selective detection and imaging of dipeptidyl peptidase IV in biological systems.
Guo X; Mu S; Li J; Zhang Y; Liu X; Zhang H; Gao H
J Mater Chem B; 2020 Jan; 8(4):767-775. PubMed ID: 31897456
[TBL] [Abstract][Full Text] [Related]
2. Activatable Near-Infrared Fluorescent Probe for Dipeptidyl Peptidase IV and Its Bioimaging Applications in Living Cells and Animals.
Liu T; Ning J; Wang B; Dong B; Li S; Tian X; Yu Z; Peng Y; Wang C; Zhao X; Huo X; Sun C; Cui J; Feng L; Ma X
Anal Chem; 2018 Mar; 90(6):3965-3973. PubMed ID: 29493228
[TBL] [Abstract][Full Text] [Related]
3. A highly specific ratiometric two-photon fluorescent probe to detect dipeptidyl peptidase IV in plasma and living systems.
Zou LW; Wang P; Qian XK; Feng L; Yu Y; Wang DD; Jin Q; Hou J; Liu ZH; Ge GB; Yang L
Biosens Bioelectron; 2017 Apr; 90():283-289. PubMed ID: 27923191
[TBL] [Abstract][Full Text] [Related]
4. A novel non-enzymatic hydrolytic probe for dipeptidyl peptidase IV specific recognition and imaging.
Xing J; Gong Q; Zhang R; Sun S; Zou R; Wu A
Chem Commun (Camb); 2018 Aug; 54(63):8773-8776. PubMed ID: 30035284
[TBL] [Abstract][Full Text] [Related]
5. Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats.
Sakai M; Uchii M; Myojo K; Kitayama T; Kunori S
Eur J Pharmacol; 2015 Aug; 761():109-15. PubMed ID: 25936515
[TBL] [Abstract][Full Text] [Related]
6. Visualizing Dipeptidyl Peptidase-IV with an Advanced Non-π-Conjugated Fluorescent Probe for Early Thyroid Disease Diagnosis.
Li J; Ma M; Li J; Xu L; Song D; Ma P; Fei Q
Anal Chem; 2023 Dec; 95(48):17577-17585. PubMed ID: 38050673
[TBL] [Abstract][Full Text] [Related]
7. A fluorescent switchable AIE probe for selective imaging of dipeptidyl peptidase-4 in vitro and in vivo and its application in screening DPP-4 inhibitors.
Wang Y; Wu X; Cheng Y; Zhao X
Chem Commun (Camb); 2016 Feb; 52(17):3478-81. PubMed ID: 26812581
[TBL] [Abstract][Full Text] [Related]
8. Detection of early adenocarcinoma of the esophagogastric junction by spraying an enzyme-activatable fluorescent probe targeting Dipeptidyl peptidase-IV.
Yamamoto K; Ohnishi S; Mizushima T; Kodaira J; Ono M; Hatanaka Y; Hatanaka KC; Kuriki Y; Kamiya M; Ehira N; Shinada K; Takahashi H; Shimizu Y; Urano Y; Sakamoto N
BMC Cancer; 2020 Jan; 20(1):64. PubMed ID: 31992267
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
10. Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.
Guida C; McCulloch LJ; Godazgar M; Stephen SD; Baker C; Basco D; Dong J; Chen D; Clark A; Ramracheya RD
Diabetes Obes Metab; 2018 Mar; 20(3):571-581. PubMed ID: 28892258
[TBL] [Abstract][Full Text] [Related]
11. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA
Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme.
Abouelkheir M; El-Metwally TH
Eur J Pharmacol; 2019 Nov; 862():172638. PubMed ID: 31491403
[TBL] [Abstract][Full Text] [Related]
13. Soybean- and Lupin-Derived Peptides Inhibit DPP-IV Activity on In Situ Human Intestinal Caco-2 Cells and Ex Vivo Human Serum.
Lammi C; Bollati C; Ferruzza S; Ranaldi G; Sambuy Y; Arnoldi A
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30104520
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo.
Kim SH; Jung E; Yoon MK; Kwon OH; Hwang DM; Kim DW; Kim J; Lee SM; Yim HJ
Eur J Pharmacol; 2016 Oct; 788():54-64. PubMed ID: 27298192
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes.
Flatt PR; Bailey CJ; Green BD
Front Biosci; 2008 May; 13():3648-60. PubMed ID: 18508462
[TBL] [Abstract][Full Text] [Related]
16. The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: Studies with HK-2 cells in vitro and normal rats in vivo.
Uchii M; Sakai M; Hotta Y; Saeki S; Kimoto N; Hamaguchi A; Kitayama T; Kunori S
J Pharmacol Sci; 2017 Nov; 135(3):126-130. PubMed ID: 29113790
[TBL] [Abstract][Full Text] [Related]
17. The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors.
Cox JM; Chu HD; Kuethe JT; Gao YD; Scapin G; Eiermann G; He H; Li X; Lyons KA; Metzger J; Petrov A; Wu JK; Xu S; Sinha-Roy R; Weber AE; Biftu T
Bioorg Med Chem Lett; 2016 Jun; 26(11):2622-6. PubMed ID: 27106708
[TBL] [Abstract][Full Text] [Related]
18. Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme.
Diez-Torrubia A; Cabrera S; de Castro S; García-Aparicio C; Mulder G; De Meester I; Camarasa MJ; Balzarini J; Velázquez S
Eur J Med Chem; 2013; 70():456-68. PubMed ID: 24185376
[TBL] [Abstract][Full Text] [Related]
19. Bestatin and bacitracin inhibit porcine kidney cortex dipeptidyl peptidase IV activity and reduce human melanoma MeWo cell viability.
Méndez LR; Arrebola Y; Valdés-Tresanco ME; Díaz-Guevara L; Bergado G; Sánchez B; Charli JL; Pascual Alonso I
Int J Biol Macromol; 2020 Dec; 164():2944-2952. PubMed ID: 32846184
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
Juillerat-Jeanneret L
J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
